Trial intelligence / Profile preview

Acupuncture Specificity in Major Depressive Disorder

NCT05353543Not yet recruiting

Sponsor
Third Affiliated Hospital of Zhejiang Chinese Medical University
Start
May 2022
Primary completion
May 2025
Countries
1
01

Overview

Randomised, double-blind trial in major depressive disorder (MDD) (3 arms), sponsored by Third Affiliated Hospital of Zhejiang Chinese Medical University. Primary endpoint: Patient Health Questionnaire-9 at 10 weeks. Planned start May 2022; status: not yet recruiting.

02

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on NCT05353543.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05353543.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call